Literature DB >> 15994929

Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.

Bramanandam Manavathi1, Sujit S Nair, Rui-An Wang, Rakesh Kumar, Ratna K Vadlamudi.   

Abstract

Proline-, glutamic acid-, and leucine-rich protein-1 (PELP1) is a novel estrogen receptor coactivator that plays an important role in the genomic and nongenomic actions of estrogen receptor by interacting with histones and src-mitogen-activated protein kinase pathway, respectively. A great deal of information has emerged in recent years about the possible role of PELP1 in estrogen receptor signaling. However, the participation and significance of PELP1 in other cellular signaling pathways remains unknown. Using a yeast two-hybrid screen, we identified PELP1 as a novel interacting protein of signal transducers and activators of transcription 3 (STAT3) and found evidence of physiologic interaction between PELP1 and STAT3. We also found that these interactions played a mechanistic role in the positive regulation of STAT3 transcription from synthetic promoters and endogenous target genes such as cyclin D1, c-myc, and c-fos. Overexpression of PELP1 enhanced phosphorylation of STAT3 at Ser727 in a src-mitogen-activated protein kinase-sensitive manner and, conversely, down-regulation of PELP1 compromised growth factor-mediated induction of STAT3 target genes. We also discovered that PELP1 interacts with STAT3 in the nuclear compartment and down-regulation of PELP1 interfered with the recruitment of STAT3 to its target gene promoters. In summary, our results highlight a novel role for PELP1 in growth factor signaling and indicate that PELP1-mediated genomic and nongenomic functions play a role in the growth factor-mediated STAT3 transactivation functions. Such regulatory interactions of PELP1 may have important functional implications in the cross-talk of estrogen receptor and growth factor signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994929      PMCID: PMC1262663          DOI: 10.1158/0008-5472.CAN-04-4664

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

Review 1.  Transcription factors as targets for cancer therapy.

Authors:  James E Darnell
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 2.  Stats: transcriptional control and biological impact.

Authors:  David E Levy; J E Darnell
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

4.  Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade.

Authors:  Chi-Wai Wong; Christopher McNally; Elliot Nickbarg; Barry S Komm; Boris J Cheskis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

5.  Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.

Authors:  Seetharaman Balasenthil; Ratna K Vadlamudi
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

6.  Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.

Authors:  R K Vadlamudi; R A Wang; A Mazumdar; Y Kim; J Shin; A Sahin; R Kumar
Journal:  J Biol Chem       Date:  2001-07-31       Impact factor: 5.157

Review 7.  Serine phosphorylation of STATs.

Authors:  T Decker; P Kovarik
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

8.  Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding.

Authors:  Lisa O'Rourke; Peter R Shepherd
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

9.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

10.  Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation.

Authors:  J J Zhang; Y Zhao; B T Chait; W W Lathem; M Ritzi; R Knippers; J E Darnell
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

View more
  29 in total

Review 1.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

2.  Regulation of aromatase induction by nuclear receptor coregulator PELP1.

Authors:  Ratna K Vadlamudi; Rajib Rajhans; Dimple Chakravarty; Binoj C Nair; Sujit S Nair; Dean B Evans; Shiuan Chen; Rajeshwar Rao Tekmal
Journal:  J Steroid Biochem Mol Biol       Date:  2009-09-30       Impact factor: 4.292

3.  Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.

Authors:  Zinovia Kefalopoulou; Vassiliki Tzelepi; Vassiliki Zolota; Petros D Grivas; Christos Christopoulos; Haralabos Kalofonos; Theodoros Maraziotis; Georgia Sotiropoulou-Bonikou
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

4.  The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1.

Authors:  Kristine M Hussey; Hongshan Chen; Christine Yang; Eugene Park; Nasun Hah; Hediye Erdjument-Bromage; Paul Tempst; Matthew J Gamble; W Lee Kraus
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

5.  Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.

Authors:  Sujit S Nair; Zhiyong Guo; Judith M Mueller; Shahriar Koochekpour; Yun Qiu; Rajeshwar Rao Tekmal; Roland Schüle; Hsing-Jien Kung; Rakesh Kumar; Ratna K Vadlamudi
Journal:  Mol Endocrinol       Date:  2006-12-27

Review 6.  PELP1: a key mediator of oestrogen signalling and actions in the brain.

Authors:  R Thakkar; G R Sareddy; Q Zhang; R Wang; R K Vadlamudi; D Brann
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

Review 7.  Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.

Authors:  Rajib Rajhans; Ratna K Vadlamudi
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

Review 8.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

9.  Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.

Authors:  Rajib Rajhans; Hareesh B Nair; Sujit S Nair; Valerie Cortez; Kijima Ikuko; Nameer B Kirma; Dujin Zhou; Alan E Holden; Darrell W Brann; Shiuan Chen; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Mol Endocrinol       Date:  2007-12-13

Review 10.  PELP1--a novel estrogen receptor-interacting protein.

Authors:  Darrell W Brann; Quan-Guang Zhang; Rui-Min Wang; Virendra B Mahesh; Ratna K Vadlamudi
Journal:  Mol Cell Endocrinol       Date:  2008-05-13       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.